Comparison of TP53 mutation prevalence in human blood cells from lung cancer patients and control subjects

Authors

  • Patrick T. Gorman University of Toledo College of Medicine Author
  • Erin L. Crawford Author https://orcid.org/0000-0002-4447-5863
  • Daniel J. Craig Author
  • James C. Willey Author

DOI:

https://doi.org/10.46570/utjms.vol11-2023-896

Keywords:

Lung Cancer, TP53, Biomarker, Research, Hematology/Oncology

Downloads

Published

2023-12-15

Issue

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium

How to Cite

1.
Comparison of TP53 mutation prevalence in human blood cells from lung cancer patients and control subjects. Translation. 2023;11(3). doi:10.46570/utjms.vol11-2023-896

Most read articles by the same author(s)